Sanjeeva Herath

Dr. Sanjeeva Herath

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
SKSradha Kotwal
Sradha Kotwal
Sanjeeva HerathSanjeeva Herath
Sanjeeva Herath
JEJonathan Erlich
Jonathan Erlich
SBSally Boardman
Sally Boardman
JQJennifer Qian
Jennifer Qian
ZEZoltán H Endre
Zoltán H Endre
Background: Early recognition of hospital-acquired acute kidney injury (AKI) may improve patient management and outcomes.Methods: This multicentre study was conducted at three hospitals (H1—intervention; H2 and H3—controls) served by a single laboratory. The intervention bundle [an interruptive automated alerts (aAlerts) showing AKI stage and baseline creatinine in the eMR, a management guide and junior medical staff education] was implemented only at H1. Outcome variables included length-of-stay (LOS), all-cause in-hospital mortality and management quality.Results: Over 6 months, 639 patients developed AKI (265 at H1 and 374 at controls), with 94.7% in general wards; 537 (84%) patients developed Stage 1, 58 (9%) Stage 2 and 43 (7%) Stage 3 AKI. Median LOS was 9 days (IQR 4–17) and was not different between intervention and controls. However, patients with AKI stage 1 had shorter LOS at H1 [median 8 versus 10 days (P = 0.021)]. Serum creatinine had risen prior to admission in most patients. Documentation of AKI was better in H1 (94.8% versus 83.4%; P = 0.001), with higher rates of nephrology consultation (25% versus 19%; P = 0.04) and cessation of nephrotoxins (25.3 versus 18.8%; P = 0.045). There was no difference in mortality between H1 versus controls (11.7% versus 13.0%; P = 0.71).Conclusions: Most hospitalized patients developed Stage 1 AKI and developed AKI in the community and remained outside the intensive care unit (ICU). The AKI eAlert bundle reduced LOS in most patients with AKI and increased AKI documentation, nephrology consultation rate and cessation of nephrotoxic medications.

1 March 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
Hyun Suk YangHyun Suk Yang
Hyun Suk Yang
Mina HurMina Hur
Mina Hur
KLKyeong Ryong Lee
Kyeong Ryong Lee
HKHanah Kim
Hanah Kim
HKHahn Young Kim
Hahn Young Kim
TNThe Great Network
The Great Network
Hyun Suk Yang, M.D., Ph.D., Mina Hur, M.D., Ph.D., Kyeong Ryong Lee, M.D., Ph.D., Hanah Kim, M.D., Ph.D., Hahn Young Kim, M.D., Ph.D., Jong Won Kim, M.D., Ph.D., Mui Teng Chua, M.D., Win Sen Kuan, M.D., Horng Ruey Chua, M.D., Chagriya Kitiyakara, M.D., Phatthranit Phattharapornjaroen, M.D., Anchalee Chittamma, Ph.D., Thiyapha Werayachankul, M.Sc., Urmila Anandh, M.D., Sanjeeva Herath, M.B., Ch.B., Zoltan Endre, M.D., Ph.D., Andrea Rita Horvath, M.D., Ph.D., Paola Antonini, M.D., and Salvatore Di Somma, M.D., Ph.D. on behalf of the GREAT Network. Ann Lab Med 2022;42:178-87. https://doi.org/10.3343/alm.2022.42.2.178

21 May 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Sanjeeva HerathSanjeeva Herath
Sanjeeva Herath
HDHongying Dai
Hongying Dai
JEJonathan Erlich
Jonathan Erlich
AAAmy Ym Au
Amy Ym Au
KTKylie Taylor
Kylie Taylor
ZEZoltán H Endre
Zoltán H Endre
Normalisation to standard reference gene(s) is essential for quantitative real-time polymerase chain reaction (RT-qPCR) to obtain reproducible and comparable results of a gene of interest (GOI) between subjects and under varying experimental conditions. There is limited evidence to support selection of the commonly used reference genes in rat ischaemic and toxicological kidney models. Employing these models, we determined the most stable reference genes by comparing 4 standard methods (NormFinder, qBase+, BestKeeper and comparative ΔCq) and developed a new 3-way linear mixed-effects model for evaluation of reference gene stability. This new technique utilises the intra-class correlation coefficient as the stability measure for multiple continuous and categorical covariates when determining the optimum normalisation factor. The model also determines confidence intervals for each candidate normalisation gene to facilitate selection and allow sample size calculation for designing experiments to identify reference genes. Of the 10 candidate reference genes tested, the geometric mean of polyadenylate-binding nuclear protein 1 (PABPN1) and beta-actin (ACTB) was the most stable reference combination. In contrast, commonly used ribosomal 18S and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were the most unstable. We compared the use of PABPN1×ACTB and 2 commonly used genes 18S and GAPDH on the expression of 4 genes of interest know to vary after renal injury and expressed by different kidney cell types (KIM-1, HIF1α, TGFβ1 and PECAM1). The less stable reference genes gave varying patterns of GOI expression in contrast to the use of the least unstable reference PABPN1×ACTB combination; this improved detection of differences in gene expression between experimental groups. Reduced within-group variation of the now more accurately normalised GOI may allow for reduced experimental group size particularly for comparison between various models. This objective selection of stable reference genes increased the reliability of comparisons within and between experimental groups.

1 December 2023 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
KTKylie M. Taylor
Kylie M. Taylor
AAAmy Y. M. Au
Amy Y. M. Au
Sanjeeva HerathSanjeeva Herath
Sanjeeva Herath
LSLena Succar
Lena Succar
JWJasmine Wong
Jasmine Wong
ZEZoltán H Endre
Zoltán H Endre
Early kidney function loss is poorly identified by serum creatinine (sCr)-based measurements. Direct kidney functional reserve (KFR) measurement before kidney injury and elevated urinary biomarkers clusterin and kidney injury molecule-1 detect subclinical chronic kidney disease (sCKD) after kidney injury despite normal range sCr and creatinine clearance. Reliance on sCr masks underlying sCKD. Acute kidney injury risk evaluation requires direct glomerular filtration rate measurement and KFR, whereas kidney damage biomarkers facilitate identification of prior subclinical injury.

2 April 2019 in Molecular Diagnosis & Therapy
Verified
Journal Article
Closed access
PDF file
Sanjeeva HerathSanjeeva Herath
Sanjeeva Herath
JEJonathan Erlich
Jonathan Erlich
AAAmy Y. M. Au
Amy Y. M. Au
ZEZoltán H Endre
Zoltán H Endre

27 June 2021 in Nephrology
Verified
Journal Article
Closed access
PDF file
DCDaniel Christiadi
Daniel Christiadi
JEJonathan Erlich
Jonathan Erlich
MLMelissa Levy
Melissa Levy
Sanjeeva HerathSanjeeva Herath
Sanjeeva Herath
JQJennifer Qian
Jennifer Qian
ZEZoltán H Endre
Zoltán H Endre